Concepedia

Pegylated (40kDa) interferon alfa-2a (PEGASYS®) in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study

Michael Fried, Mitchell L. Shiffman, R. Reddy, Coleman Smith, George Marino, F. Goncales, D. Haeussinger, M. Diago, Giampietro Carosl, Jean‐Pierre Zarski,

Gastroenterology · 2001 · 104 citations · 0 references

Open access

Concepts

PharmacyPharmacologyPharmacotherapyBiopharmaceuticsClinical PharmacologyAntiviral PharmacologyAntiviral TherapyInterferon ResponsesInterferon-based TherapyViral Hepatitis TreatmentAntiviral Interferon ResponsesInterferon Alfa TherapyInterferon Alpha-2b TherapyMulticenter TrialsPegylated Interferon AlfaRibavirin TherapyRibavirin-based RegimensViral Kinetics